Factors predicting missing instruments in three cancer randomized clinical trials

被引：0
|
作者：
Michael J. Palmer
Harriet Richardson
Dongsheng Tu
Michael Brundage
机构：
[1] Queen’s University,Department of Public Health Sciences
[2] Queen’s University,Cancer Care and Epidemiology, Cancer Research Institute
[3] Queen’s University,Canadian Cancer Trials Group, Cancer Research Institute
[4] Queen’s University,Division of Cancer Care and Epidemiology, Cancer Research Institute
来源：
Quality of Life Research | 2021年 / 30卷
关键词：
Factors; Missing patient-reported outcome data; Missing instruments; Randomized clinical trials; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2219 / 2234
页数：15
相关论文
共 50 条
  • [31] Patterns of Scientific and Clinical Impact in Cancer Randomized Clinical Trials
    Nghiem, Van T.
    Vaidya, Riha
    Unger, Joseph M.
    JAMA NETWORK OPEN, 2022, 5 (06) : E2219657
  • [32] Estimation of Treatment Effect with Missing Observations for Three Arms and Three Periods Crossover Clinical Trials
    Bhattacharjee A.
    Annals of Data Science, 2020, 7 (03): : 447 - 460
  • [33] The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
    Drexel, Heinz
    Lewis, Basil S.
    Rosano, Giuseppe M. C.
    Saely, Christoph H.
    Tautermann, Gerda
    Huber, Kurt
    Dopheide, Joern F.
    Kaski, Juan Carlos
    Mader, Arthur
    Niessner, Alexander
    Savarese, Gianluigi
    Schmidt, Thomas A.
    Semb, AnneGrete
    Tamargo, Juan
    Wassmann, Sven
    Kjeldsen, Keld Per
    Agewall, Stefan
    Pocock, Stuart J.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 453 - 459
  • [34] Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials
    Logan, Jennifer K.
    Tang, Chad
    Liao, Zhongxing
    Lee, J. Jack
    Heymach, John V.
    Swisher, Stephen G.
    Welsh, James W.
    Zhang, Jianjun
    Lin, Steven H.
    Gomez, Daniel R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 770 - 777
  • [35] STUDY OF THREE INSTRUMENTS FOR PREDICTING RECIDIVISM
    Luis Basanta, Juan
    Fandino, Ricardo
    PSICOLOGIA JURIDICA: CONOCIMIENTO Y PRACTICA, 2017, 14 : 315 - 329
  • [36] Factors associated with altmetric attention scores for randomized phase III cancer clinical trials.
    Rooney, Michael Kevin
    Ludmir, Ethan B.
    Fuller, Clifton Dave
    Warner, Jeremy Lyle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Statistical analysis of quality of life with missing data in cancer clinical trials
    Troxel, AB
    Fairclough, DL
    Curran, D
    Hahn, EA
    STATISTICS IN MEDICINE, 1998, 17 (5-7) : 653 - 666
  • [38] NON-RANDOMIZED CONTROLS IN CANCER CLINICAL TRIALS
    GEHAN, EA
    FREIREICH, EJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (04): : 198 - 203
  • [39] RANDOMIZED CLINICAL-TRIALS IN CANCER-CHEMOTHERAPY
    RAZIS, DV
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1979, 72 (05) : 390 - 391
  • [40] A Method to Summarize Toxicity in Cancer Randomized Clinical Trials
    Carbini, Mariana
    Suarez-Farinas, Mayte
    Maki, Robert G.
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 4968 - 4975
12345